Video
Dr. Laviana on novel opioid minimization protocol after urologic robotic surgery
Author(s):
"We wanted to implement an opioid minimization pathway that was easy to follow and successful,” says Aaron Laviana, MD.
Video Player is loading.
Aaron Laviana, MD, MBA, discusses the background and results of the study, “Decreased opioid use & equivalent pain score outcomes after urologic robotic surgery using a simplified opioid minimization protocol: a prospective, non-inferiority study,” which he presented at the 2022 AUA Annual Meeting (abstract MP31-02)
Laviana Assistant is a professor of Surgery and Perioperative Care at the University of Texas at Austin Dell Medical School.
Related Videos
5 key trial insights from AUA 2025
Shreyas Joshi, MD, recaps AUA session on chemotherapy vs novel NMIBC options
Shay Rajavel, MS3, on CO2 gas embolism during single-port partial nephrectomy
Kevin Zorn, MD, on preserving ejaculation with BPH therapies
Neal Shore, MD, on sasanlimab plus BCG for BCG-naïve NMIBC
Alexander Glaser, MD, on real-world outcomes with Aquablation
Vitaly Margulis, MD, on preliminary safety, efficacy of padeliporfin VTP for UTUC
Joseph Jacob, MD, on the durability of TAR-200 in NMIBC
Margaret Knoedler, MD, on Ho:YAG vs thulium fiber laser for ureteroscopy
John Gore, MD, on radical cystectomy vs bladder-sparing therapy for NMIBC
Related Content
